Pentec Health Announces Appointment of New Executive Vice President of Quality and Regulatory Affairs

Share Article

Hiring of FDA Veteran Underscores Company’s Commitment to Quality and Patient Safety

Pentec Health, Inc. announced the appointment of Dr. David Pulham, Ph.D., a 27-year veteran of the U.S. Food and Drug Administration (FDA), to the newly created position of Executive Vice President, Quality and Regulatory Affairs. Dr. Pulham, in his new role, will report to Pentec Chairman, CEO and President, Mr. Joseph Cosgrove. In announcing the appointment, Cosgrove stated "Dr. Pulham brings a wealth of experience to this newly created and essential position within our organization. David will have an immediate impact in enhancing our quality assurance and regulatory affairs capabilities and will be an essential player as Pentec expands its footprint within the increasingly regulated outsourced pharmacy arena. His hiring reflects our company’s continued focus on patient safety and regulatory compliance as well as our commitment to having an industry-leading quality assurance program."

During the last 15 of his 27 years at the FDA, Dr. Pulham was the agency's National Expert Investigator in aseptic processing and biometrics, enjoying international recognition for his expertise in these areas. During the course of his FDA career, his other responsibilities included global enforcement of current Good Manufacturing Practice (GMP) requirements for drugs, devices and biologics, training of industry and FDA Investigators, and conducting Pre-Approval and routine GMP inspections throughout the world. Following his government tenure, David worked at Lachman Consultant Services, providing regulatory compliance, quality and audit expertise to the life sciences industry, and served as Senior Vice President of Global Compliance at Siegfried Ltd., a global drug development and manufacturing services firm, where he was responsible for FDA, DEA, EPA,and OSHA compliance.

In a new organizational structure, Pharmacy, Pharmacy Operations, Quality Assurance and Compliance functions will now be under Dr. Pulham's direction. Dr. Pulham commented, "I am honored to have been asked to assume this important transformational role at Pentec Health, guiding the company through the always, and increasingly, complex Federal and State regulatory environments. I am clearly excited about the opportunity to join Joe and his amazing leadership team as we continue to position the company to enjoy future diversified growth."

Dr. Pulham holds bachelors degrees in Mathematics and Medical Technology, a Masters Degree in Pharmacokinetics and a Ph.D. in Pharmacology. David currently resides in New Jersey with his wife, Magdalena.

About Pentec Health, Inc.
For 33 years, Pentec Health has been an industry leader in providing outsourced, physician prescribed, custom prepared, patient-specific, compounded, sterile medications that are intended for patient administration in the home as well as various alternate administration sites. For more information, please visit

Pentec Health, Inc.
Monique Costa

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Monique Costa
+1 (856) 906-7833
Email >

Stephanie Boayue
Visit website